Marilena Tauro, PhD, on ULK3 as a Novel Target in MM

Marilena Tauro, PhD, of the Moffitt Cancer Center, discusses her presentation on novel strategies to overcome chemotherapy resistance in multiple myeloma (MM) at the American Association for Cancer Research Annual Meeting 2023.

Dr. Tauro explains the rationale behind the study, how it addresses unmet needs in the field, why ULK3 represents a novel target in MM, and the next steps with the research.